Home> Products> reducing glucose reabsorption

{ "products": [ { "_id": "6a1d7da71f450faabc228b8d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "gliclazide sr 60mg and Dapagliflozin 10mg tablet", "description": "Managing Type 2 diabetes requires a comprehensive approach that helps control blood sugar levels while reducing the risk of long-term complications. The Gliclazide and Dapagliflozin combination is a modern and effective treatment option prescribed by healthcare professionals to improve glycemic control in adults with Type 2 diabetes mellitus. This combination works through two different mechanisms to help maintain healthy blood glucose levels, making it a preferred choice for patients who need better diabetes management.\n\nIf you are looking for a reliable diabetes treatment option, understanding the benefits, uses, and working mechanism of the Gliclazide and Dapagliflozin combination can help you make an informed decision in consultation with your healthcare provider.\n\nWhat is Gliclazide and Dapagliflozin Combination?\n\nThe Gliclazide and Dapagliflozin combination is an oral anti-diabetic medication used to control blood sugar levels in patients with Type 2 diabetes. It combines two powerful medicines:\n\nGliclazide – A sulfonylurea that stimulates the pancreas to release more insulin.\nDapagliflozin – An SGLT2 inhibitor that helps the kidneys remove excess glucose through urine.\n\nTogether, these medicines provide dual-action blood sugar control and help patients achieve better glycemic targets when diet, exercise, and single-drug therapy are insufficient.\n\nHow Does Gliclazide and Dapagliflozin Combination Work?\n\nThe effectiveness of this combination lies in its complementary mechanisms of action.\n\nGliclazide Action\n\nGliclazide works by stimulating the beta cells in the pancreas to produce and release more insulin. Increased insulin production helps transport glucose from the bloodstream into body cells, where it is used for energy.\n\nDapagliflozin Action\n\nDapagliflozin blocks the Sodium-Glucose Co-Transporter 2 (SGLT2) protein in the kidneys. This action reduces glucose reabsorption and allows excess sugar to be eliminated through urine, lowering blood glucose levels.\n\nCombined Benefits\n\nWhen used together, Gliclazide and Dapagliflozin help:\n\nReduce fasting blood sugar levels\nLower post-meal glucose spikes\nImprove HbA1c levels\nSupport long-term diabetes management\nProvide complementary glucose-lowering effects\nUses of Gliclazide and Dapagliflozin Combination\n\nHealthcare professionals commonly prescribe this combination for:\n\nType 2 Diabetes Mellitus\n\nThe primary use of the Gliclazide and Dapagliflozin combination is the treatment of Type 2 diabetes in adults whose blood sugar levels are not adequately controlled by lifestyle modifications alone.\n\nImproved Glycemic Control\n\nThis medication helps patients achieve better glycemic control and maintain stable blood glucose levels throughout the day.\n\nCombination Diabetes Therapy\n\nIt is often recommended when monotherapy with a single anti-diabetic medication fails to provide satisfactory results.\n\nLong-Term Diabetes Management\n\nThe combination can be used as part of a comprehensive diabetes management plan that includes healthy eating, exercise, and regular monitoring.\n\nBenefits of Gliclazide and Dapagliflozin Combination\n1. Dual Mechanism of Action\n\nThe combination attacks high blood sugar from two different angles, resulting in more effective glucose control.\n\n2. Better HbA1c Reduction\n\nPatients often experience significant reductions in HbA1c levels compared to treatment with a single medication.\n\n3. Effective Fasting and Postprandial Control\n\nThe medicine helps manage both fasting blood glucose and post-meal sugar spikes.\n\n4. Convenient Treatment Option\n\nCombining two medications into one treatment regimen can improve patient compliance and simplify diabetes management.\n\n5. Supports Weight Management\n\nUnlike some traditional diabetes medications, Dapagliflozin may contribute to modest weight reduction due to the elimination of excess glucose through urine.\n\n6. Cardiovascular Benefits\n\nDapagliflozin has been associated with cardiovascular benefits in certain patients, making it an attractive option for individuals with Type 2 diabetes and cardiovascular risk factors.\n\n7. Reduced Risk of Diabetes Complications\n\nMaintaining better blood sugar control may help reduce the risk of complications affecting the eyes, kidneys, nerves, and cardiovascular system.\n\nWhy Choose Gliclazide and Dapagliflozin Combination?\n\nThe growing popularity of this combination therapy stems from its ability to provide comprehensive blood sugar management. Physicians often recommend it because:\n\nIt targets multiple pathways involved in glucose regulation.\nIt provides strong glycemic control.\nIt helps reduce HbA1c effectively.\nIt offers potential weight-related benefits.\nIt supports long-term diabetes care goals.\n\nPatients seeking improved diabetes control often find this combination beneficial when prescribed and monitored by a healthcare professional.\n\nRecommended Dosage\n\nThe dosage of the Gliclazide and Dapagliflozin combination should always be determined by a healthcare provider based on:\n\nAge\nBlood glucose levels\nHbA1c values\nMedical history\nKidney function\nResponse to treatment\n\nPatients should take the medication exactly as prescribed and should not alter the dosage without medical advice.\n\nPrecautions Before Using Gliclazide and Dapagliflozin Combination\n\nBefore starting treatment, inform your doctor if you have:\n\nKidney disease\nLiver disorders\nHeart conditions\nFrequent urinary tract infections\nHistory of diabetic ketoacidosis\nSevere dehydration\nLow blood pressure\n\nPregnant and breastfeeding women should consult their healthcare provider before using this medication.\n\nPossible Side Effects\n\nLike all medications, the Gliclazide and Dapagliflozin combination may cause side effects in some individuals.\n\nCommon Side Effects\nIncreased urination\nThirst\nHeadache\nDizziness\nFatigue\nMild gastrointestinal discomfort\nHypoglycemia Symptoms\n\nSince Gliclazide stimulates insulin release, some patients may experience low blood sugar, especially when meals are skipped.\n\nSymptoms may include:\n\nSweating\nHunger\nTrembling\nWeakness\nConfusion\nRapid heartbeat\nUrinary and Genital Infections\n\nDapagliflozin increases glucose excretion through urine, which may increase the likelihood of:\n\nUrinary tract infections\nGenital fungal infections\n\nPrompt medical attention should be sought if symptoms occur.\n\nLifestyle Tips for Better Diabetes Control\n\nFor optimal results with the Gliclazide and Dapagliflozin combination, patients should follow a healthy lifestyle.\n\nMaintain a Balanced Diet\n\nFocus on:\n\nWhole grains\nVegetables\nFruits in moderation\nLean proteins\nHealthy fats\n\nAvoid excessive consumption of sugary foods and beverages.\n\nExercise Regularly\n\nPhysical activity helps improve insulin sensitivity and supports blood sugar control. Aim for at least 150 minutes of moderate exercise per week, as advised by your healthcare provider.\n\nMonitor Blood Sugar\n\nRegular blood glucose monitoring helps track treatment effectiveness and allows timely adjustments when necessary.\n\nStay Hydrated\n\nBecause Dapagliflozin increases urinary glucose excretion, adequate hydration is important to prevent dehydration.\n\nAttend Regular Checkups\n\nRoutine medical visits help monitor:\n\nHbA1c levels\nKidney function\nBlood pressure\nOverall diabetes control\nWho Can Benefit from Gliclazide and Dapagliflozin Combination?\n\nThis combination may be suitable for:\n\nAdults with Type 2 diabetes\nPatients requiring stronger glucose control\nIndividuals not achieving targets with single-drug therapy\nPatients seeking a dual-action diabetes treatment approach\nIndividuals requiring comprehensive glycemic management under medical supervision\nConclusion\n\nThe Gliclazide and Dapagliflozin combination is an advanced and effective treatment option for adults with Type 2 diabetes mellitus. By combining the insulin-stimulating action of Gliclazide with the glucose-eliminating benefits of Dapagliflozin, this therapy provides comprehensive blood sugar control and supports long-term diabetes management goals.\n\nWith benefits such as improved HbA1c reduction, fasting and post-meal glucose control, convenient therapy, and potential cardiovascular advantages, this combination has become an important choice in modern diabetes care. When used alongside a healthy diet, regular exercise, and proper medical supervision, the Gliclazide and Dapagliflozin combination can help patients achieve better glycemic control and improve their overall quality of life.", "price": 470.0, "discountamount": 141.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2433, "imageuri": "https://productimages.withfloats.com/actual/6a1d7da92f2aa2676dd01915.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a1d7da92f2aa2676dd01915.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-01T12:40:07.196Z", "updatedon": "2026-06-04T07:19:16.331Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclazide-sr-60mg-and-dapagliflozin-10mg-tablet/2433", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Gliclaglaze DAPA 60-10", "category": "DIABETIC RANGE", "tags": [ "gliclazide and dapagliflozin combination", "gliclazide sr 60mg and Dapagliflozin 10mg tablet", "gliclazide and dapagliflozin", "gliclazide and dapagliflozin together", "gliclazide dapagliflozin", "Gliclazide SR 60 mg and Dapagliflozin 10 mg Tablets", "Buy Gliclazide SR 60 mg Dapagliflozin 10 mg Tablets Online", "Type 2 Diabetes Treatment Tablets", "Gliclazide and Dapagliflozin Diabetes Medicine", "Gliclazide SR 60 mg Dapagliflozin 10 mg Product Image", "Best Tablets for Type 2 Diabetes Management", "Blood Sugar Control Tablets Gliclazide Dapagliflozin", "Gliclazide SR and Dapagliflozin Combination Tablets", "Diabetes Management Medicine Gliclazide Dapagliflozin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "698d91909e3c03f732124005", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Remogliflozin Etabonate Tablets 100 mg", "description": "REMOFLOZIN 100 is an advanced oral antidiabetic medication containing Remogliflozin Etabonate 100 mg as its active pharmaceutical ingredient. This innovative formulation represents a significant breakthrough in the management of Type 2 Diabetes Mellitus, offering patients a novel mechanism of action that works independently of insulin secretion or insulin sensitivity. REMOFLOZIN 100 belongs to the sodium-glucose co-transporter 2 (SGLT2) inhibitors class of medications, which has revolutionized diabetes management by targeting glucose reabsorption in the kidneys rather than affecting pancreatic function or peripheral glucose utilization.\nDeveloped through rigorous scientific research and clinical trials, REMOFLOZIN 100 provides diabetic patients with an effective therapeutic option that not only helps control blood sugar levels but also offers additional cardiovascular and metabolic benefits. Each tablet is precisely formulated to deliver consistent and reliable glycemic control, making it an essential component in the comprehensive management of Type 2 Diabetes.\nHow REMOFLOZIN 100 Works\nThe mechanism of action of REMOFLOZIN 100 is both unique and highly effective. Under normal physiological conditions, the kidneys filter glucose from the blood, but the SGLT2 proteins in the proximal renal tubules reabsorb approximately 90% of this filtered glucose back into the bloodstream. In diabetic patients, this reabsorption continues even when blood glucose levels are elevated, perpetuating hyperglycemia.\nRemogliflozin Etabonate works by selectively inhibiting the SGLT2 proteins in the kidneys, thereby reducing glucose reabsorption and increasing urinary glucose excretion. This insulin-independent mechanism allows the body to eliminate excess glucose naturally through urine, leading to sustained reductions in blood glucose levels. The medication typically begins working within hours of administration, with maximum therapeutic effects observed within several weeks of consistent use.\nPrimary Uses and Indications\nREMOFLOZIN 100 is primarily indicated for:\nManagement of Type 2 Diabetes Mellitus: As monotherapy in patients who cannot tolerate metformin or for whom metformin is contraindicated, and as combination therapy with other antidiabetic agents including metformin, sulfonylureas, or insulin when existing treatment regimens fail to achieve adequate glycemic control.\nGlycemic Control Optimization: For patients requiring additional blood sugar management beyond diet and exercise modifications, REMOFLOZIN 100 helps reduce both fasting plasma glucose and postprandial glucose levels.\nAdjunct to Lifestyle Modifications: The medication works synergistically with dietary modifications and regular physical activity to achieve comprehensive diabetes management and reduce the risk of long-term diabetic complications.\nKey Benefits of REMOFLOZIN 100\nSuperior Glycemic Control\nREMOFLOZIN 100 demonstrates significant efficacy in reducing HbA1c levels, typically achieving reductions of 0.5% to 1.0% when used as monotherapy and even greater reductions when combined with other antidiabetic medications. This improvement in long-term glucose control translates to reduced risk of microvascular complications, including diabetic retinopathy, nephropathy, and neuropathy.\nWeight Management Support\nUnlike many traditional antidiabetic medications that may cause weight gain, REMOFLOZIN 100 is associated with modest weight loss, typically ranging from 2 to 4 kilograms over several months of treatment. This weight reduction occurs due to caloric loss through urinary glucose excretion and may provide additional metabolic benefits for overweight or obese diabetic patients.\nCardiovascular Benefits\nEmerging research on SGLT2 inhibitors suggests potential cardiovascular protective effects, including modest reductions in blood pressure and improvements in various cardiovascular risk markers. These benefits may be particularly valuable for diabetic patients who are at increased risk of cardiovascular disease.\nLow Risk of Hypoglycemia\nBecause REMOFLOZIN 100 works independently of insulin secretion, it carries a minimal risk of hypoglycemia when used as monotherapy. This safety profile makes it particularly suitable for elderly patients or those at higher risk of dangerous low blood sugar episodes.\nRenal Function Considerations\nThe medication may offer nephroprotective benefits by reducing intraglomerular pressure and proteinuria in diabetic patients, potentially slowing the progression of diabetic kidney disease.\nConvenient Once-Daily Dosing\nREMOFLOZIN 100's pharmacokinetic profile allows for convenient once-daily administration, improving patient compliance and treatment adherence.\nPotential Side Effects and Safety Considerations\nWhile REMOFLOZIN 100 is generally well-tolerated, patients should be aware of potential side effects:\nCommon Side Effects\n\nGenital Mycotic Infections: Increased glucose in urine may promote fungal infections, particularly in women\nUrinary Tract Infections: More frequent urination and glucose in urine may increase UTI risk\nIncreased Urination: Polyuria is expected due to the medication's mechanism of action\nThirst: Patients may experience increased thirst due to fluid loss\nDizziness: Particularly when standing up quickly, due to mild blood pressure reductions\n\nSerious but Rare Side Effects\n\nDiabetic Ketoacidosis: Although rare, euglycemic DKA has been reported with SGLT2 inhibitors\nAcute Kidney Injury: Dehydration may affect kidney function in susceptible individuals\nLower Limb Amputation: Some SGLT2 inhibitors have shown increased risk in specific populations\nHypotension: Particularly in patients on diuretics or with compromised cardiovascular function\n\nContraindications and Precautions\nREMOFLOZIN 100 should not be used in patients with type 1 diabetes, severe renal impairment, diabetic ketoacidosis, or those with known hypersensitivity to the drug. Pregnant and breastfeeding women should avoid this medication. Patients should maintain adequate hydration and practice proper genital hygiene to minimize infection risks.\nDosage and Administration Guidelines\nThe standard recommended dose is one REMOFLOZIN 100 tablet taken orally once daily, preferably at the same time each day. The medication can be taken with or without food. Patients should not double doses if they miss a scheduled dose but should take the next dose at the regular time. Dosage adjustments may be necessary based on individual response, renal function, and concomitant medications. Regular monitoring of blood glucose levels, kidney function, and HbA1c is essential for optimal treatment management.\nConclusion\nREMOFLOZIN 100 represents a valuable therapeutic advancement in type 2 diabetes management, offering patients an innovative approach to glycemic control through its unique renal mechanism of action. The medication's ability to reduce blood sugar levels while providing additional benefits such as weight loss, cardiovascular protection, and low hypoglycemia risk makes it an attractive option for many diabetic patients.", "price": 335.0, "discountamount": 101.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2301, "imageuri": "https://productimages.withfloats.com/actual/698d9191cd6033ecce84b352.png", "tileimageuri": "https://productimages.withfloats.com/tile/698d9191cd6033ecce84b352.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-12T08:38:40.037Z", "updatedon": "2026-03-13T11:02:30.281Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//remogliflozin-etabonate-tablets-100-mg/2301", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REMOFLOZIN 100", "category": "DIABETIC RANGE", "tags": [ "Remogliflozin Etabonate 100mg tablets for type 2 diabetes", "Remogliflozin 100mg oral diabetes medication", "Remogliflozin Etabonate tablets 100mg prescription", "Remogliflozin 100 mg SGLT2 inhibitor tablets", "Remogliflozin Etabonate 100mg diabetes control tablets", "Buy Remogliflozin 100mg tablets online", "Remogliflozin Etabonate 100mg pack price", "Remogliflozin 100mg tablets for blood sugar management" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6810aa8d5a26e4010ea41a99", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 12.5mg ,Metformin Hydrochloride 500mg", "description": "EMPATECH MET 12.5/500 is a powerful oral antidiabetic combination therapy containing Empagliflozin and Metformin Hydrochloride, designed to manage Type 2 Diabetes Mellitus effectively. This dual-action formula helps control blood sugar levels, supports weight management, and offers added cardiovascular benefits. EMPATECH MET 12.5/500 is particularly beneficial for adults who require a second-line treatment when diet, exercise, and monotherapy are not sufficient.\n\nKey Ingredients\nEmpagliflozin (12.5 mg):\nA sodium-glucose co-transporter-2 (SGLT2) inhibitor that helps reduce blood glucose levels by promoting glucose excretion through urine.\n\nMetformin Hydrochloride (500 mg):\nA biguanide class medication that lowers blood glucose by improving insulin sensitivity and reducing glucose production in the liver.\n\nKey Benefits\nHelps in lowering and maintaining stable blood glucose levels\n\nPromotes weight loss and reduces visceral fat\n\nReduces the risk of cardiovascular complications in diabetic patients\n\nSupports renal protection in people with diabetes and mild kidney dysfunction\n\nOffers a low risk of hypoglycemia compared to some other therapies\n\nImproves glycemic control with a dual mechanism of action\n\nHow Does It Work?\nEMPATECH MET 12.5/500 functions through two complementary mechanisms:\n\nEmpagliflozin works by blocking SGLT2 proteins in the kidneys, reducing the reabsorption of glucose and increasing its excretion via urine. This lowers blood sugar levels independently of insulin action.\n\nMetformin acts primarily by inhibiting hepatic glucose production and improving the body’s sensitivity to insulin, allowing for better uptake and usage of glucose by muscles and fat tissues.\n\nTogether, they provide a comprehensive glycemic control strategy, especially for patients not responding well to monotherapy.\n\nDirections for Use\nTake the tablet as prescribed by your doctor, usually once or twice daily with meals.\n\nSwallow the tablet whole with water; do not crush or chew.\n\nContinue following a healthy diet and regular exercise routine for optimal results.\n\nMonitor blood sugar levels regularly and report any unusual changes to your healthcare provider.\n\nDo not stop the medication without medical advice, even if your blood sugar levels improve.\n\nSide Effects\nCommon Side Effects:\n\nIncreased urination\n\nThirst or dry mouth\n\nNausea or mild gastrointestinal upset\n\nHeadache\n\nFatigue\n\nLess Common but Serious Side Effects:\n\nRisk of urinary tract infections or genital infections\n\nLactic acidosis (rare but serious; associated with Metformin)\n\nDehydration or low blood pressure, especially in elderly patients\n\nElectrolyte imbalances\n\nSeek immediate medical help if you experience severe abdominal pain, muscle cramping, breathing difficulties, or unusual tiredness.", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "unusual tiredness", "medical advice", "monotherapy directions", "healthcare provider", "healthy diet", "chew continue", "meals swallow", "fat tissues", "dual mechanism", "hypoglycemia compared", "cardiovascular complications", "secondline treatment", "metformin dehydration", "insulin allowing", "bodys sensitivity", "kidneys reducing", "low risk", "diet exercise", "improving insulin sensitivity", "promoting glucose excretion", "reducing glucose production", "side effects risk", "biguanide class medication", "lowers blood glucose", "low blood pressure", "regular exercise routine", "metformin hydrochloride designed", "urinary tract infections", "dry mouth nausea", "blocking sglt2 proteins" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2093, "imageuri": "https://productimages.withfloats.com/actual/6810aa8f5c4a4ba3d41a8c35.png", "tileimageuri": "https://productimages.withfloats.com/tile/6810aa8f5c4a4ba3d41a8c35.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-04-29T10:31:41.504Z", "updatedon": "2026-04-15T06:40:21.664Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-12-5mg-metformin-hydrochloride-500mg/2093", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EMPATECH MET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg price", "empagliflozin 12.5 mg+metformin 1000 mg", "empagliflozin 12.5mg brands in india", "empagliflozin metformin hydrochloride", "buy empagliflozin metformin hydrochloride", "empagliflozin metformin hydrochloride tablet", "buy empagliflozin metformin hydrochloride online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "67e1547f527b20030c4156f0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 5 mg and Metformin Hydrochloride 500 mg", "description": "EMPATECH MET 5/500 is a powerful combination of Empagliflozin 5 mg and Metformin Hydrochloride 500 mg designed to effectively manage Type 2 Diabetes Mellitus. It helps control blood sugar levels, improves insulin sensitivity, and reduces the risk of diabetes-related complications. This dual-action formula works by limiting glucose absorption while enhancing the body's natural ability to utilize insulin, making it a preferred choice for diabetic patients seeking optimal glycemic control.\n \nKey Benefits:\nEffective Blood Sugar Control – Lowers HbA1c levels and maintains stable glucose levels.\nSupports Weight Management – Promotes calorie loss by eliminating excess glucose.\nReduces Cardiovascular Risk – Empagliflozin has heart-protective benefits, reducing the risk of heart-related complications.\nImproves Insulin Sensitivity – Helps the body use insulin more effectively.\nReduces the Risk of Hypoglycemia – Lowers blood sugar without excessive insulin spikes.\n\nHow Does It Work?\n\nEmpagliflozin blocks the SGLT2 (Sodium-Glucose Co-Transporter 2) in the kidneys, preventing glucose reabsorption and allowing excess sugar to be excreted through urine.\nMetformin decreases glucose production in the liver and enhances insulin sensitivity, helping the body use glucose more efficiently.\nTogether, they provide comprehensive diabetes management by regulating blood sugar without causing significant hypoglycemia.\n \nDirections for Use:\n \n\nTake EMPATECH MET 5/500 as prescribed by your doctor.\n\nSwallow the tablet whole with water, preferably with meals to minimize stomach discomfort.\n\nMaintain a balanced diet and regular exercise for optimal results.\n\nDo not stop or change the dosage without consulting your doctor.\n\n \nSide Effects:\n \n\nWhile EMPATECH MET 5/500 is generally well-tolerated, some individuals may experience:\n\nFrequent Urination – Due to glucose excretion in urine.\nMild Stomach Discomfort – Including nausea, bloating, or diarrhea.\nDizziness or Weakness – Especially in the initial stages of treatment.\nUrinary Tract Infections (UTIs) – A possible side effect of increased glucose in urine.\nLactic Acidosis (Rare but Serious) – Symptoms include muscle pain, breathing difficulty, or extreme tiredness; seek medical attention if these occur.", "price": 115.0, "discountamount": 35.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "effectively reduces", "increased glucose", "initial stages", "diarrhea dizziness", "nausea bloating", "glucose excretion", "generally welltolerated", "optimal results", "regular exercise", "balanced diet", "water preferably", "empatech met 5500", "preferred choice", "diabetesrelated complications", "powerful combination", "side effect", "doctor swallow", "empagliflozin 5mg", "doctor side effects", "limiting glucose absorption", "excessive insulin spikes", "utilize insulin making", "work empagliflozin blocks", "regulating blood sugar", "allowing excess sugar", "heartprotective benefits reducing", "bodys natural ability", "dualaction formula works" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2074, "imageuri": "https://productimages.withfloats.com/actual/67e15496bb48c9c5202ecea6.png", "tileimageuri": "https://productimages.withfloats.com/tile/67e15496bb48c9c5202ecea6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-24T12:47:59.972Z", "updatedon": "2026-03-13T10:02:45.025Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-5-mg-and-metformin-hydrochloride-500-mg/2074", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EMPATECH MET 5/500", "category": "DIABETIC RANGE", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin 12.5 mg+metformin 500 mg price", "empagliflozin + metformin combination brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "67e1538c204f0ac1d74d3bc3", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 10 mg ", "description": "EMPATECH 10 contains Empagliflozin 10 mg, a highly effective oral medication used for the management of type 2 diabetes mellitus. It helps regulate blood sugar levels by promoting glucose excretion through urine, reducing the risk of complications like heart disease and kidney damage. With its unique action, EMPATECH 10 not only aids in diabetes control but also supports overall cardiovascular and renal health.\n \nKey Benefits:\n\nEffective Blood Sugar Control – Lowers blood glucose levels and improves diabetes management.\nSupports Weight Management – Aids in weight loss by eliminating excess glucose.\nReduces Risk of Cardiovascular Diseases – Helps protect the heart and lower the risk of heart failure.\nPromotes Kidney Health – Prevents diabetic kidney damage by reducing strain on the kidneys.\nLowers Blood Pressure – Has a mild diuretic effect, which helps in managing hypertension.\n\nHow Does It Work?\n\nEmpagliflozin works by inhibiting the SGLT2 protein in the kidneys, preventing glucose reabsorption into the bloodstream. This results in excess glucose being excreted through urine, thereby lowering blood sugar levels naturally. Unlike insulin-based treatments, it works independently of insulin secretion, making it a beneficial option for many patients.\n \nDirections for Use:\n\nTake EMPATECH 10 exactly as prescribed by your doctor.\nSwallow the tablet whole with water, preferably once daily in the morning.\nIt can be taken with or without food.\nMaintain a healthy diet and exercise routine for best results.\nDo not stop the medication without consulting your healthcare provider.\n\nSide Effects:\n\nWhile EMPATECH 10 is generally well-tolerated, some individuals may experience:\nFrequent Urination\nIncreased Thirst\nUrinary Tract Infections (UTIs)\nDizziness or Low Blood Pressure\nGenital Infections (in some cases)\n\nIf you experience severe dehydration, allergic reactions, or persistent infections, seek medical help immediately.", "price": 135.0, "discountamount": 41.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "empatech 10", "heart disease", "urine reducing", "generally welltolerated", "exercise routine", "healthy diet", "food maintain", "water preferably", "doctor swallow", "patients directions", "beneficial option", "sglt2 protein", "managing hypertension", "reducing strain", "weight loss", "diabetes control", "kidney damage", "empagliflozin 10mg", "empagliflozin 10mgempatech 10", "works independently", "excess glucose", "work empagliflozin works", "promoting glucose excretion", "insulin secretion making", "mild diuretic effect" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2073, "imageuri": "https://productimages.withfloats.com/actual/67e1539d6530786450c6e761.png", "tileimageuri": "https://productimages.withfloats.com/tile/67e1539d6530786450c6e761.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-24T12:43:56.598Z", "updatedon": "2026-03-13T09:49:28.667Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-10-mg-/2073", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EMPATECH 10", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin 10 mg uses", "Empagliflozin 10 mg brand name", "Empagliflozin 10 mg brands in India", "Empagliflozin 10 mg Tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "67e152b7204f0ac1d74d3bb7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin 10 mg sitagliptin 100 mg", "description": "GLIEMPAFLOZIN SITA 10/100 is a powerful combination of Empagliflozin 10 mg and Sitagliptin 100 mg designed to effectively manage Type 2 Diabetes Mellitus. This dual-action formula helps regulate blood sugar levels, improves insulin sensitivity, and supports overall metabolic health. It is ideal for individuals who require an advanced approach to diabetes management while reducing the risk of complications.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control – Helps maintain stable glucose levels throughout the day.\nDual-Action Formula – Targets blood sugar from different pathways for enhanced efficacy.\nWeight Management Support – Aids in mild weight loss by reducing excess glucose.\nCardiovascular Protection – May lower the risk of heart-related complications.\nReduces Risk of Hypoglycemia – Less likelihood of sudden blood sugar drops compared to some other diabetes medications.\nHow Does It Work?\nEmpagliflozin works by preventing glucose reabsorption in the kidneys, allowing excess sugar to be eliminated through urine.\nSitagliptin increases insulin production while reducing the liver’s glucose output, leading to improved blood sugar control.\nTogether, these ingredients offer a comprehensive diabetes treatment approach, making it easier to maintain healthy glucose levels.\nDirections for Use:\nTake GLIEMPAFLOZIN SITA 10/100 as prescribed by your doctor.\nSwallow the tablet whole with a glass of water.\nCan be taken with or without food.\nMaintain a balanced diet and regular exercise for best results.\nDo not exceed the recommended dosage.\nSide Effects:\nWhile generally well-tolerated, some individuals may experience:\nIncreased Urination\nMild Nausea or Stomach Discomfort\nHeadache or Dizziness\nUrinary Tract Infections (UTIs)\nLow Blood Pressure (in some cases)\nSeek medical attention if you experience severe allergic reactions, dehydration, or persistent discomfort.", "price": 365.0, "discountamount": 110.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "generally welltolerated", "regular exercise", "balanced diet", "food maintain", "doctor swallow", "gliempaflozin sita 10100", "ingredients offer", "diabetes medications", "diabetes management", "advanced approach", "metabolic health", "powerful combination", "persistent discomfort", "empagliflozin 10mg", "stomach discomfort headache", "work empagliflozin works", "preventing glucose reabsorption", "mild weight loss", "sitagliptin 100mg designed" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2072, "imageuri": "https://productimages.withfloats.com/actual/67e152c98868d014155bafa6.png", "tileimageuri": "https://productimages.withfloats.com/tile/67e152c98868d014155bafa6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-24T12:40:23.819Z", "updatedon": "2026-04-02T12:37:59.857Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-10-mg-sitagliptin-100-mg/2072", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN SITA 10/100", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and sitagliptin combination", "Empagliflozin and sitagliptin tablets", "Empagliflozin and sitagliptin combination brands", "Empagliflozin and sitagliptin tablets", "empagliflozin 10 mg sitagliptin 100 mg uses", "empagliflozin sitagliptin tablets benefits", "empagliflozin and sitagliptin combination tablets uses in hindi", "empagliflozin sitagliptin tablets for diabetes control", "empagliflozin sitagliptin tablets side effects", "empagliflozin sitagliptin tablets for blood sugar control", "empagliflozin 10 mg sitagliptin 100 mg price", "empagliflozin sitagliptin tablets b2b supplier", "best price empagliflozin sitagliptin tablets india", "empagliflozin 10 mg and sitagliptin 100 mg tablets for type 2 diabetes", "best empagliflozin sitagliptin tablets for blood sugar control in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "67e151dde76674b1ca044d32", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 25 mg and Sitagliptin 100 mg", "description": "GLIEMPAFLOZIN SITA 25/100 is an advanced anti-diabetic medication containing Empagliflozin 25 mg and Sitagliptin 100 mg, formulated to effectively control blood sugar levels in individuals with Type 2 Diabetes Mellitus. This powerful combination helps regulate glucose levels, improve insulin function, and reduce the risk of diabetes-related complications. It is designed for patients requiring dual therapy to achieve better glycemic control.\n\n \nKey Benefits:\n \nEffective Blood Sugar Control – Lowers HbA1c levels and maintains long-term glycemic stability.\nPromotes Weight Loss – Empagliflozin helps in reducing excess body weight by eliminating excess glucose.\nHeart & Kidney Protection – Reduces the risk of cardiovascular diseases and kidney complications.\nEnhanced Insulin Sensitivity – Improves insulin response and minimizes glucose spikes.\nConvenient Dual Therapy – Combines two powerful anti-diabetic agents in one tablet for better diabetes management.\n\n \nHow Does It Work?\n \n\nEmpagliflozin blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting glucose excretion through urine. This helps lower blood sugar levels naturally while supporting heart and kidney health.\n\nSitagliptin works by inhibiting the DPP-4 enzyme, which increases the levels of incretin hormones that stimulate insulin release and reduce glucose production in the liver.\n\nTogether, they offer comprehensive diabetes control by lowering blood sugar through different mechanisms, making it a superior option for Type 2 Diabetes management.\n\n \nDirections for Use:\n \n\nTake GLIEMPAFLOZIN SITA 25/100 as prescribed by your doctor.\n\nSwallow the tablet whole with water, preferably once daily with or without food.\n\nMaintain a healthy diet and regular exercise for best results.\n\nDo not exceed the recommended dosage without consulting a healthcare professional.\n\n \nSide Effects:\n \n\nWhile generally well-tolerated, some users may experience:\n\nFrequent Urination (due to glucose excretion)\nDehydration & Dizziness\nMild Nausea or Stomach Discomfort\nHypoglycemia (Low Blood Sugar) – Especially if combined with insulin or sulfonylureas\nUrinary or Genital Infections (due to increased sugar excretion in urine)\n\nSeek medical attention if you experience severe allergic reactions, persistent dizziness, or signs of dehydration.", "price": 425.0, "discountamount": 128.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "sulfonylureas urinary", "generally welltolerated", "recommended dosage", "regular exercise", "healthy diet", "food maintain", "water preferably", "doctor swallow", "gliempaflozin sita 25100", "superior option", "mechanisms making", "incretin hormones", "dpp4 enzyme", "supporting heart", "sglt2 protein", "diabetes management", "cardiovascular diseases", "diabetesrelated complications", "empagliflozin 25mg", "reduce glucose production", "stimulate insulin release", "work empagliflozin blocks", "increased sugar excretion", "genital infections due", "lowering blood sugar", "promoting glucose excretion", "powerful antidiabetic agents", "sitagliptin 100mg formulated", "advanced antidiabetic medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2071, "imageuri": "https://productimages.withfloats.com/actual/67e151f4a5330495f6fabda3.png", "tileimageuri": "https://productimages.withfloats.com/tile/67e151f4a5330495f6fabda3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-24T12:36:45.699Z", "updatedon": "2026-03-13T09:45:12.512Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-25-mg-and-sitagliptin-100-mg/2071", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN SITA 25/100", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and sitagliptin combination", "Empagliflozin 25 mg substitute", "Empagliflozin 25 mg brands in India", "Empagliflozin 25 mg Price in India", "Empagliflozin brands in India", "Empagliflozin 25 mg", "Empagliflozin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "67a35e1c4d6823e26538d21d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 12.5mg, Metformin Hydrochloride 500mg", "description": "GLIEMPAFLOZIN MET 12.5mg/500mg is a powerful combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (12.5mg) and Metformin Hydrochloride (500mg), two potent anti-diabetic agents that work synergistically to regulate blood sugar levels. This medication helps in improving glycemic control while reducing the risk of diabetes-related complications. It is prescribed as an adjunct to diet and exercise to enhance blood glucose regulation in adults with type 2 diabetes.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control: Helps in lowering HbA1c levels, leading to better long-term glucose management.\nPromotes Weight Loss: Empagliflozin assists in weight reduction by eliminating excess glucose through urination.\nReduces Cardiovascular Risk: Beneficial for patients with heart-related complications linked to diabetes.\nImproves Insulin Sensitivity: Metformin enhances insulin action, reducing insulin resistance.\nPrevents Kidney Damage: Helps in reducing the burden on kidneys by decreasing glucose reabsorption.\nConvenient Combination Therapy: Eliminates the need for multiple medications by combining two effective drugs in one tablet.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 12.5mg/500mg works through a dual mechanism:\n\nEmpagliflozin blocks SGLT2 in the kidneys, preventing glucose reabsorption and promoting its excretion through urine. This leads to a significant reduction in blood sugar levels.\n\nMetformin lowers hepatic glucose production, decreases intestinal glucose absorption, and enhances insulin sensitivity, ensuring better blood glucose utilization by the body.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\n\nSwallow the tablet whole with a glass of water. Do not crush or chew it.\nIt is recommended to take the medication with food to minimize gastrointestinal side effects.\nFollow a balanced diet and regular exercise regimen for optimal results.\nMonitor blood sugar levels regularly to ensure proper dosage adjustments.\nSide Effects:\n\nAlthough GLIEMPAFLOZIN MET 12.5mg/500mg is well tolerated, some patients may experience mild to moderate side effects, including:\n\nFrequent Urination due to glucose excretion\n\nDehydration or thirst\n\nHypoglycemia (Low Blood Sugar) when used with other anti-diabetic medications\nGastrointestinal Issues such as nausea, diarrhea, or stomach discomfort\nUrinary Tract Infections (UTIs) due to increased glucose in urine\nLactic Acidosis (Rare but Serious) in some cases due to Metformin", "price": 145.0, "discountamount": 44.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet daily", "balanced diet", "medication helps", "nausea diarrhea", "experience mild", "body directions", "significant reduction", "effective drugs", "multiple medications", "weight reduction", "work synergistically", "empagliflozin 125mg", "cases due", "diabetesrelated complications", "increased glucose", "glucose excretion dehydration", "regular exercise regimen", "metformin hydrochloride 500mg", "frequent urination due", "heartrelated complications linked", "blood glucose utilization", "eliminating excess glucose", "moderate side effects", "gliempaflozin met 125mg500mg", "healthcare provider swallow", "improving glycemic control", "potent antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2050, "imageuri": "https://productimages.withfloats.com/actual/67a35e57b167fbeb7927d316.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35e57b167fbeb7927d316.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:48:28.684Z", "updatedon": "2026-03-13T09:41:22.601Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-12-5mg-metformin-hydrochloride-500mg/2050", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 12.5mg/ 500mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg", "empagliflozin/metformin 5 mg/1000 mg", "Empagliflozin 12.5 mg brands in India", "empagliflozin 12.5 mg+metformin 500 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }